ENTITY

Mira Pharmaceuticals (MIRA US)

Analysis

Health Care • United States

Mira Pharmaceuticals, Inc. operates as a biotech company. The Company develops prescription drug to target the CB1 and CB2 receptors for chronic pain and anxiety without the impurities of marijuana or its side effects such as increased appetite and paranoia. Mira Pharmaceuticals serves customers worldwide.

Refresh

Focused

No publications yet

There aren’t any buy-side reports right now

Back to "All"

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00